Eli Lilly & Co will invest $3 billion in China over the next decade to expand local production, with a focus on weight loss as the US drugmaker looks to cement its dominance in the booming obesity market.
Insurance giant fined 10.6m for balance sheet errors before Aviva takeover
...
Read moreDetails